Published in Neurogastroenterol Motil on August 01, 2006
Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2011) 1.49
The immune system in irritable bowel syndrome. J Neurogastroenterol Motil (2011) 1.16
Diagnosis and management of IBS. Nat Rev Gastroenterol Hepatol (2010) 1.14
Mast cells in gastrointestinal disease. Gastroenterol Hepatol (N Y) (2010) 1.10
Lifestyle and psychological factors related to irritable bowel syndrome in nursing and medical school students. J Gastroenterol (2011) 1.00
Irritable bowel syndrome: the role of food in pathogenesis and management. Gastroenterol Hepatol (N Y) (2014) 0.91
New treatments for irritable bowel syndrome in women. Womens Health (Lond Engl) (2008) 0.88
HLA-DQ genotype is associated with accelerated small bowel transit in patients with diarrhea-predominant irritable bowel syndrome. Eur J Gastroenterol Hepatol (2011) 0.87
Interaction between ingested nutrients and gut endocrine cells in patients with irritable bowel syndrome (review). Int J Mol Med (2014) 0.85
Recent developments in the pathophysiology of irritable bowel syndrome. World J Gastroenterol (2015) 0.84
Allergic mastocytic gastroenteritis and colitis: an unexplained etiology in chronic abdominal pain and gastrointestinal dysmotility. Gastroenterol Res Pract (2012) 0.83
Diet in subjects with irritable bowel syndrome: a cross-sectional study in the general population. BMC Gastroenterol (2012) 0.83
Irritable bowel syndrome and food interaction. World J Gastroenterol (2014) 0.82
Diet in irritable bowel syndrome. Nutr J (2015) 0.81
Symptom pattern following a meal challenge test in patients with irritable bowel syndrome and healthy controls. United European Gastroenterol J (2013) 0.81
Indication of immune activation in patients with perceived food hypersensitivity. Dig Dis Sci (2013) 0.80
Risk factors for chronic diarrhoea in the community in the absence of irritable bowel syndrome. Neurogastroenterol Motil (2009) 0.79
Pathophysiologic findings of irritable bowel syndrome in china. J Neurogastroenterol Motil (2012) 0.79
Current and emerging therapies for the management of functional gastrointestinal disorders. Ther Adv Chronic Dis (2011) 0.78
Should milk-specific IgE antibodies be measured in adults in primary care? Scand J Prim Health Care (2008) 0.78
Cow's milk protein sensitivity assessed by the mucosal patch technique is related to irritable bowel syndrome in patients with primary Sjögren's syndrome. Clin Exp Allergy (2008) 0.78
Changes in the Interstitial Cells of Cajal and Immunity in Chronic Psychological Stress Rats and Therapeutic Effects of Acupuncture at the Zusanli Point (ST36). Evid Based Complement Alternat Med (2016) 0.78
Functional Gastrointestinal Symptoms Are Associated with Higher Serum Total IgE Levels, but Less Atopic Sensitization. Dig Dis Sci (2015) 0.77
Use of the Biphasic (13)C-Sucrose/Glucose Breath Test to Assess Sucrose Maldigestion in Adults with Functional Bowel Disorders. Biomed Res Int (2016) 0.75
Discrepancies between the responses to skin prick test to food and respiratory antigens in two subtypes of patients with irritable bowel syndrome. World J Gastroenterol (2008) 0.75
Alcohol Use Disorder Increases the Risk of Irritable Bowel Disease: A Nationwide Retrospective Cohort Study. Medicine (Baltimore) (2015) 0.75
Lipopolysaccharides facilitate colonic motor alterations associated to the sensitization to a luminal antigen in rats. J Neurogastroenterol Motil (2015) 0.75
Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology (1997) 2.71
Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings. Gut (1987) 2.46
Performance characteristics of scintigraphic transit measurements for studies of experimental therapies. Aliment Pharmacol Ther (2002) 2.37
Assessment of gastric accommodation: overview and evaluation of current methods. Neurogastroenterol Motil (2004) 2.28
Definition and investigation of dyspepsia. Consensus of an international ad hoc working party. Dig Dis Sci (1989) 2.23
Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion. Gastroenterology (1986) 2.03
Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil (2007) 1.98
Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma. Gastroenterology (1991) 1.98
Serotonin: a mediator of the brain-gut connection. Am J Gastroenterol (2000) 1.93
Transit of solids through the human colon: regional quantification in the unprepared bowel. Am J Physiol (1990) 1.90
A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther (2003) 1.85
Is there a role for gastric accommodation and satiety in asymptomatic obese people? Obes Res (2001) 1.84
Relation between antral motility and gastric emptying of solids and liquids in humans. Am J Physiol (1985) 1.81
Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroenterology (1997) 1.80
Relationship between impaired gastric emptying and abnormal gastrointestinal motility. Gastroenterology (1986) 1.79
Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment Pharmacol Ther (2012) 1.79
Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans. Gastroenterology (2000) 1.74
Performance characteristics of scintigraphic colon transit measurement in health and irritable bowel syndrome and relationship to bowel functions. Neurogastroenterol Motil (2009) 1.73
Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies. Neurogastroenterol Motil (2011) 1.72
Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder. Gastroenterology (2001) 1.64
Scintigraphic measurement of regional gut transit in idiopathic constipation. Gastroenterology (1991) 1.63
Human enteric neuropathies: morphology and molecular pathology. Neurogastroenterol Motil (2004) 1.63
Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med (2000) 1.61
A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil (2005) 1.60
[13C]octanoic acid breath test for gastric emptying of solids: accuracy, reproducibility, and comparison with scintigraphy. Gastroenterology (1997) 1.59
Adrenergic modulation of human colonic motor and sensory function. Am J Physiol (1997) 1.59
Abnormal intestinal motility in diabetics with the gastroparesis syndrome. Eur J Clin Invest (1984) 1.59
Scintigraphy of the whole gut: clinical evaluation of transit disorders. Mayo Clin Proc (1995) 1.58
Development of a test to measure gastric accommodation in humans. Am J Physiol (1999) 1.56
Colonic transit scintigraphy labeled activated charcoal compared with ion exchange pellets. J Nucl Med (1997) 1.54
Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans. Gut (2003) 1.53
Gastric mechanosensory and lower esophageal sphincter function in rumination syndrome. Am J Physiol (1998) 1.51
Optimizing analysis of stable isotope breath tests to estimate gastric emptying of solids. Neurogastroenterol Motil (2009) 1.51
The rumination syndrome: clinical features rather than manometric diagnosis. Gastroenterology (1995) 1.50
Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology (1986) 1.49
Effects of erythromycin on gut transit in pseudo-obstruction due to hereditary coproporphyria. J Clin Gastroenterol (1992) 1.48
Idiopathic autonomic neuropathy: clinical, neurophysiologic, and follow-up studies on 27 patients. Neurology (1994) 1.47
Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects. Gut (2008) 1.47
Colonic tone and motility in patients with irritable bowel syndrome. Mayo Clin Proc (1992) 1.46
Psychosensory modulation of colonic sensation in the human transverse and sigmoid colon. Gastroenterology (1995) 1.46
Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterology (2000) 1.45
Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea. N Engl J Med (1993) 1.45
Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans. Gastroenterology (1999) 1.42
Gastrointestinal manifestations of systemic vasculitis. Q J Med (1983) 1.41
Transit through the proximal colon influences stool weight in the irritable bowel syndrome. Gastroenterology (1992) 1.41
Opioids and the gut: pharmacology and current clinical experience. Neurogastroenterol Motil (2004) 1.40
Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials. Neurogastroenterol Motil (2003) 1.39
Serotonergic mediation of postprandial colonic tonic and phasic responses in humans. Gut (1994) 1.37
Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics. Am J Gastroenterol (2001) 1.36
Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort. Neurogastroenterol Motil (2009) 1.35
Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting. Neurogastroenterol Motil (2009) 1.32
American Gastroenterological Association medical position statement on anorectal testing techniques. American Gastroenterological Association. Gastroenterology (1999) 1.32
Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans. Gut (1999) 1.31
Audit of constipation in a tertiary referral gastroenterology practice. Am J Gastroenterol (1995) 1.30
Descending perineum syndrome: audit of clinical and laboratory features and outcome of pelvic floor retraining. Am J Gastroenterol (1999) 1.30
Gender-related differences in slowing colonic transit by a 5-HT3 antagonist in subjects with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol (2001) 1.29
Effect of age on the enteric nervous system of the human colon. Neurogastroenterol Motil (2009) 1.29
Effects of an alpha(2)-adrenergic agonist on gastrointestinal transit, colonic motility, and sensation in humans. Am J Physiol Gastrointest Liver Physiol (2001) 1.28
Differences in colonic tone and phasic response to a meal in the transverse and sigmoid human colon. Gut (1995) 1.25
Rectal tone, distensibility, and perception: reproducibility and response to different distensions. Am J Physiol (1998) 1.24
Noninvasive measurement of gastric accommodation in patients with idiopathic nonulcer dyspepsia. Am J Gastroenterol (2001) 1.23
Effects of a serotonin 5-HT(4) receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans. Gut (2000) 1.23
Reproducibility and simplification of 13C-octanoic acid breath test for gastric emptying of solids. Am J Gastroenterol (1998) 1.22
Variation of muscle tone in the human colon. Gastroenterology (1991) 1.22
Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function. Gut (1999) 1.22
Apoptotic cell death of human interstitial cells of Cajal. Neurogastroenterol Motil (2008) 1.20
Effect of cyclooxygenase-2 inhibitors on gastric emptying and small intestinal transit in humans. Neurogastroenterol Motil (2004) 1.19
Ileocolonic transfer of solid chyme in small intestinal neuropathies and myopathies. Gastroenterology (1990) 1.19
Autonomic dysfunction in gastrointestinal motility disorders. Gut (1993) 1.18
Gastric electromechanical and neurohormonal function in anorexia nervosa. Gastroenterology (1987) 1.18
Psychological disorders in patients with evacuation disorders and constipation in a tertiary practice. Am J Gastroenterol (2000) 1.18
Gastric and autonomic responses to stress in functional dyspepsia. Dig Dis Sci (1986) 1.18
Gastrointestinal motility disturbances in patients with orthostatic hypotension. Gastroenterology (1985) 1.16
Effect of female sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in postmenopausal women. Neurogastroenterol Motil (2006) 1.15
Gastric axial forces in experimentally delayed and accelerated gastric emptying. Am J Physiol (1993) 1.15
A 5HT3 antagonist corrects the postprandial colonic hypertonic response in carcinoid diarrhea. Gastroenterology (1994) 1.14
Comparison of the postural tachycardia syndrome (POTS) with orthostatic hypotension due to autonomic failure. J Auton Nerv Syst (1994) 1.14
Neurohormonal factors in functional dyspepsia: insights on pathophysiological mechanisms. Gastroenterology (1991) 1.14
Effects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation. Neurogastroenterol Motil (2009) 1.14
Evaluation of an inexpensive screening scintigraphic test of gastric emptying. J Nucl Med (1995) 1.13
Mechanisms in IBS: something old, something new, something borrowed... Neurogastroenterol Motil (2005) 1.13
Barostat testing of rectal sensation and compliance in humans: comparison of results across two centres and overall reproducibility. Neurogastroenterol Motil (2005) 1.13
Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus. Gastroenterology (1995) 1.13
Chronic intestinal pseudo-obstruction: diagnosis and treatment. Mayo Clin Proc (1989) 1.13
A valid, accurate, office based non-radioactive test for gastric emptying of solids. Gut (2000) 1.11
Review article: metoclopramide and tardive dyskinesia. Aliment Pharmacol Ther (2010) 1.11
Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition. Am J Physiol Gastrointest Liver Physiol (2000) 1.11
First-in-human study demonstrating pharmacological activation of heme oxygenase-1 in humans. Clin Pharmacol Ther (2009) 1.10
Validation of a stable isotope gastric emptying test for normal, accelerated or delayed gastric emptying. Neurogastroenterol Motil (2001) 1.10
Impaired transit of chyme in chronic intestinal pseudoobstruction. Correction by cisapride. Gastroenterology (1986) 1.08
Adynamic ileus in severe Guillain-Barré syndrome. Muscle Nerve (2001) 1.07
Motility and tone of the left colon in constipation: a role in clinical practice? Am J Gastroenterol (1996) 1.07
Comparison of gastric volumes in response to isocaloric liquid and mixed meals in humans. Neurogastroenterol Motil (2004) 1.07
Intestinal pseudo-obstruction. Annu Rev Med (1999) 1.07
Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD). Neurogastroenterol Motil (2012) 1.07
Coloanal motor coordination in association with high-amplitude colonic contractions after pharmacological stimulation. Am J Gastroenterol (2000) 1.06
Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus. Neurogastroenterol Motil (2002) 1.05
Effects of glucagon-like peptide-1 and feeding on gastric volumes in diabetes mellitus with cardio-vagal dysfunction. Neurogastroenterol Motil (2003) 1.05